Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels

INTRODUCTION AND OBJECTIVE: Despite the improvements in management and treatment of chordomas over time, the risk of disease recurrence remains high. Consequently, there is a push to develop effective systemic therapeutics for newly diagnosed and recurrent disease. In order to tailor treatment for i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubino, Franco, Alvarez-Breckenridge, Christopher, Akdemir, Kadir, Conley, Anthony P., Bishop, Andrew J., Wang, Wei-Lien, Lazar, Alexander J., Rhines, Laurence D., DeMonte, Franco, Raza, Shaan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557284/
https://www.ncbi.nlm.nih.gov/pubmed/36248987
http://dx.doi.org/10.3389/fonc.2022.997506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557284/
https://www.ncbi.nlm.nih.gov/pubmed/36248987
http://dx.doi.org/10.3389/fonc.2022.997506

Ejemplares similares